Five Rivers RX
  • Home
  • Free Consultation
  • Clients
    • Manufacturers
    • Distributors
      • Drug, Device, and Supply Distributors
      • External Distributors
    • Logistics
    • Providers & Dispensers
  • Services
    • State Compliance Services
      • Initial Assessment
      • Obtaining New Licenses
      • On-going Renewals
      • Quality & Compliance Support
    • Business Strategy & Consulting
    • Certified Designated Representative Training Courses
    • DEA Compliance
    • FDA Reporting
    • NABP Drug Distributor Accreditation (VAWD)
    • Pharmacy Accreditations
      • URAC Specialty Pharmacy
      • URAC Mail Service Pharmacy
      • ACHC Specialty Pharmacy
      • ACHC Retail or DMEPOS Pharmacy
      • PCAB Compounding Pharmacy
      • VIPPS Internet Pharmacy
      • LegitScript
      • Verified Pharmacy Program (VPP)
      • .Pharmacy (or DotPharmacy)
    • Pharmacy Solutions
      • General Pharmacy Consulting
      • Immunization Protocols
      • Policy and Procedure Development
      • Chronic Care Management
    • Puerto Rico Services
  • Company
    • Leadership
    • Team
    • Careers
    • Testimonials & Accolades
  • Resources
    • Assessments
    • State Regulatory Agencies
    • Webinars
    • Courses
  • Industry Insight & Blog
  • Contact Us
    • Contact Us
    • Our Locations
Select Page
State Licensing & Regulation: Pharmacy-Wholesalers

State Licensing & Regulation: Pharmacy-Wholesalers

by Five Rivers Rx | Feb 26, 2019 | Regulations

Patchwork of Regulation As anyone who works in the state licensing realm can tell you, the system of state licensing for pharmaceutical entities is a true patchwork of different rules and regulations. Each state has its own regulatory system. Differences may range...
FDA Begins DSCSA Enforcement on Distributors

FDA Begins DSCSA Enforcement on Distributors

by Five Rivers Rx | Jan 4, 2019 | Industry News, Regulations

The first-time inspection of a wholesale drug distributor for DSCSA requirements is a warning to industry: be prepared for a knock on the door by the FDA. Why It’s Important For the very first time, the US Food and Drug Administration (FDA) performed an inspection and...
Major Wholesalers Anti-Diversion Program Challenged

Major Wholesalers Anti-Diversion Program Challenged

by Five Rivers Rx | Oct 9, 2018 | Regulations

Background In a letter dated May 23, 2018, AmerisourceBergen threatened to stop supply to Bernie’s Pharmacy because of “an elevated percentage of opioid purchasing…specifically, it was noted that in recent months between 25-50% of all pharmacy purchases of Rx products...
4th Largest US Wholesaler has DEA Registration Suspended

4th Largest US Wholesaler has DEA Registration Suspended

by Five Rivers Rx | May 9, 2018 | Competition, Industry News

In an attempt to rein in the Opioid Epidemic, it seems that recently, the DEA has become more vigilant on Suspicious Order Monitoring and Reporting. May 7 Update Morris and Dickson was awarded a temporary restraining order which allows them to continue transacting...

The Potential Doom of the Oligopoly in Pharmaceutical Distribution: How Amazon Can Hurt the Big 3’s Future for Profit & Sales Growth

by Five Rivers Rx | Aug 10, 2017 | Competition

The Big 3 have controlled over 90% of the wholesale drug market for over 10 years. At that size, they are close to a zero-sum game… there is no new business to win except from each other or through acquisitions that are limited on supply.   PROFIT & SALES GROWTH...
« Older Entries

Recent Posts

  • DSCSA Update: Breaking Case Packs & Adoption Increases
  • A Failure of Legislation or Rulemaking? Virtual Manufacturers & Maine
  • Proposed Rules for DEA Suspicious Orders
  • Industry Comments on Iowa’s Drug Distributor Accreditation Requirement
  • NavigateSOM Releases User Manual

Archives

  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016

Categories

  • Competition
  • Compounding Quality Act
  • DEA
  • Drug Importation
  • Drug Manufacturers
  • Five Rivers
  • Industry News
  • NABP
  • NavigateSOM
  • Optum Rx
  • Puerto Rico
  • Regulations
  • Suspicious Order Monitoring
  • Uncategorized
  • VAWD
  • VDIP

Contact Us

 

705 Montgomery Ave., Suite 200
Penn Valley, PA 19072

E: hello@fiveriversrx.com
P: 800.962.8760

Socialize

  • Follow
  • Follow

Subscribe to Our Newsletter

Success!

Subscribe

© 2020 – Five Rivers RX – All rights reserved

     

    Subscribe to Our Newsletter